Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta234

Important information about this guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 280.